InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,859.20
(
1.11%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.43
(
-1.03%
)
Bitcoin
56,467.37
(
-0.90%
)
Post# of 426469
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

nutsyprofessor

Send PM Follow Ignore
Followers 18
Posts 2369
Boards Moderated 0
Alias Born 01/09/2012

nutsyprofessor

Re: johnking29 post# 24860

Saturday, 01/25/2014 4:43:02 PM

Saturday, January 25, 2014 4:43:02 PM

Post# of 426469
John: not sure there is a reason to call anyone. To me the whole thing is pretty straight forward and transparent.

Vascepa will not be considered as a treatment for TG levels in the 200-499 range for the simple fact that there are no clinical trials showing proof that Omega-3 products reduce CVE's/CVD?

On the other hand, there is extensive clinical proof that statin use was associated with significantly improved survival and large reductions in the risk of major cardiovascular events.

So I'm not sure what people don't understand about these facts. The AHA would wholeheartedly agree with these facts.

DISCLAIMER - HIGH RISK/REWARD - POSTS ON THIS BOARD MAY OR MAY NOT BE FACTUAL

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News
InvestorsHub NewsWire

Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM

Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM

EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM

BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM

NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

Start posting your company's news
Only $200 per official company press release!